Cu(I)-N-Heterocyclic carbenes as potent inhibitors of SARS-CoV-2 replication (2026)
Source: BioMetals. Unidade: IFSC
Subjects: COVID-19, PLANEJAMENTO DE FÁRMACOS, COMPOSTOS ORGANOMETÁLICOS
ABNT
SANTOS, Igor de Andrade et al. Cu(I)-N-Heterocyclic carbenes as potent inhibitors of SARS-CoV-2 replication. BioMetals, v. 39, p. 681-699 + supporting information, 2026Tradução . . Disponível em: https://doi.org/10.1007/s10534-025-00775-6. Acesso em: 25 abr. 2026.APA
Santos, I. de A., Fontes, J. V., Rodrigues, G. C., Godoy, M. O. de, Oliva, G., Guido, R. V. C., et al. (2026). Cu(I)-N-Heterocyclic carbenes as potent inhibitors of SARS-CoV-2 replication. BioMetals, 39, 681-699 + supporting information. doi:10.1007/s10534-025-00775-6NLM
Santos I de A, Fontes JV, Rodrigues GC, Godoy MO de, Oliva G, Guido RVC, Merits A, Abbehausen C, Harris M, Jardim ACG. Cu(I)-N-Heterocyclic carbenes as potent inhibitors of SARS-CoV-2 replication [Internet]. BioMetals. 2026 ; 39 681-699 + supporting information.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s10534-025-00775-6Vancouver
Santos I de A, Fontes JV, Rodrigues GC, Godoy MO de, Oliva G, Guido RVC, Merits A, Abbehausen C, Harris M, Jardim ACG. Cu(I)-N-Heterocyclic carbenes as potent inhibitors of SARS-CoV-2 replication [Internet]. BioMetals. 2026 ; 39 681-699 + supporting information.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1007/s10534-025-00775-6

